Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases?
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 21 (4) , 131-133
- https://doi.org/10.1016/s0165-6147(00)01458-9
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Role of tachykinin NK2‐receptor activation in the allergen‐induced late asthmatic reaction, airway hyperreactivity and airway inflammatory cell influx in conscious, unrestrained guinea‐pigsBritish Journal of Pharmacology, 1999
- Role of tachykinins as contractile agonists of human airways in asthmaClinical and Experimental Allergy, 1999
- Identification of a δ isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytesJournal of Neuroimmunology, 1998
- Bronchial Mucosal Immunoreactivity of Sensory Neuropeptides in Severe Airway DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Neurogenic Amplification of Immune Complex InflammationScience, 1996
- The effect of inhaled FK224, a tachykinin NK-1 and NK-2 receptor antagonist, on neurokinin A-induced bronchoconstriction in asthmatics.American Journal of Respiratory and Critical Care Medicine, 1996
- A neurokinin 1-receptor antagonist improves exercise-induced airway narrowing in asthmatic patients.American Journal of Respiratory and Critical Care Medicine, 1996
- Effect of an NK1 receptor antagonist (CP-99,994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects.American Journal of Respiratory and Critical Care Medicine, 1995
- Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroidsJournal of Molecular Endocrinology, 1993
- Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonistThe Lancet, 1992